Having graduated from Stanford University with a degree in Biology, in addition to studying International Relations and Comparative East Asian Industrial Economics at Sophia University in Tokyo, Joel L. Bellenson went on to become the Co-Founder and CEO of Pangea Systems/DoubleTwist, which assembled and annotated the first draft of the Human Genome, provided low cost access to academics and kept it from being patented. The company pioneered large-scale gene expression and protein-expression informatics analysis and was voted #1 privately held biotech company in the world by Red Herring Magazine in 1998 and 1999.
Bellenson was also the Co-Founder and CEO of DigiScents which pioneered digital scent synthesis as well as the Co-Founder and CEO of Upstream Biosciences which used artificial intelligence software to discover new medicines against drug-resistant tropical infectious diseases such as African Sleeping Sickness, Malaria, and Black Fever.
The scientist, entrepreneur, visionary and author currently resides in Vancouver, BC, Canada.
Equal Watts, Joel Lloyd Bellenson added by A R on
View all posts by A R →
You must be logged in to post a comment Login